Hims & Hers Health (HIMS) reported Q1 earnings Monday of $0.20 per diluted share, up from $0.05 a year earlier.

Analysts polled by FactSet expected $0.12.

Revenue for the quarter ended March 31 was $586.0 million, up from $278.2 million a year earlier.

Analysts surveyed by FactSet expected $538.6 million.

Gross margin was 73% for Q1, compared with 82% a year ago.

The company said it expects Q2 revenue of $530 million to $550 million. Analysts expected $564.6 million.

The company reiterated 2025 revenue guidance of $2.3 billion to $2.4 billion. Analysts expected $2.33 billion.